Structure and Function of CB2 Cannabinoid Receptor
CB2 大麻素受体的结构和功能
基本信息
- 批准号:7440803
- 负责人:
- 金额:$ 4.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-30 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:Absence of pain sensationAdverse effectsAffinityAffinity ChromatographyAgonistAgreementAmino AcidsAnalgesicsArtsAutoimmune DiseasesBindingBiochemicalBiogenic Amine ReceptorsCNR2 geneCannabinoidsCellular biologyCharacteristicsChemicalsClassCloningCollaborationsConditionConserved SequenceCysteineDecompression SicknessDevelopmentDisulfide LinkageDisulfidesDopamine D2 ReceptorEnsureEthersEthyl EtherExhibitsFamilyFingerprintFluorescence SpectroscopyFutureG-Protein-Coupled ReceptorsGlaucomaGoalsGrowthHelix (Snails)Hydrogen BondingHydroxyl RadicalImmuneImmune systemImmunologic ReceptorsInflammationIonsLigand BindingLigandsLiquid ChromatographyMapsMarijuanaMass Spectrum AnalysisMedicalMetalsMethodologyMethodsModelingModificationMolecularMolecular BiologyMolecular ConformationMutagenesisMutationNatureNeuraxisNuclear Magnetic ResonanceNumbersPeptide FragmentsPeptidesPeripheralPharmaceutical PreparationsPharmacologyPichiaPositioning AttributePost-Translational Protein ProcessingProceduresProcessProductionProlinePropertyProtein ChemistryProtein OverexpressionProteinsProteomicsPurposeReceptor ActivationResearch DesignResearch PersonnelResearch ProposalsResolutionRhodopsinRunningSiteSourceSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStructureSurfaceSystemTestingTherapeuticTherapeutic AgentsTimeTissuesTransmembrane DomainWorkX-Ray CrystallographyYeastsbasecannabinoid receptordesigndisulfide bondear heliximprovedinsightmimeticsmolecular modelingnovelprogramsprotein aminoacid sequenceprotein structurereceptorreceptor structure functionscale uptool
项目摘要
The long-term goal of this research proposal is to identify the molecular basis underlying the functions of
the CB2 cannabinoid receptor. To achieve this purpose, the following steps will be taken. In Aim 1 and 2,
the interactive mutagenesis, molecular modeling and new compound testing studies will be carried out.
This combined approach has advanced our understanding, and should continue to reveal new insights on
how cannabinoid ligands are recognized by their receptors, the origin of receptor subtype-selectivity, and
how _these receptors are activated/inactivated. Cannabinoid receptors share many of the conserved
sequence motifs seen in other well-studied G protein-coupled receptors (GPCRs), such as rhodopsin and
biogenic amine receptors. However, several helix-bending residues and motifs, and a key disulfide
bridge present in many other GPCRs are missing in cannabinoid receptors. In Aim 3, Ligand binding
crevice exposure of two transmembrane domains of CB2 cannabinoid receptor will be mapped using
substituted-cysteine accessibility method. This approach should elucidate structural and functional
consequences of the sequence divergence in these trasmembrane domains of cannabinoid receptors. In
Aim 4, Disulfide bond formation of CB2 receptor will be determined directly by the state-of-art
methodologies of mass spectrometry. Investigating the unique disulfide bond or absence of a disulfide
bond should provide important helix folding information of CB2 receptor, and this will have important
implications regarding ligand binding crevice and activation mechanisms of this receptor. Finally, in Aim
5, effort will be devoted to over-express and purify large amounts of functional CB2 receptor. This
challenging task, if successfully completed, should have a significant impact by providing the badly
needed pure receptor proteins for future high-resolution biophysical studies. Overall, This study should
help us to understand in more molecular detail the structure and function of CB2 receptor. CB2 is
primarily distributed in the immune system. It is very important for the immune-modulatory effects of
marijuana. In the long run, this study should also help us to develop better cannabinoid mimetics for the
treatment of immune system illnesses, such as inflammation and autoimmune diseases. The drugs that
soecifi(;allv taroeted at CB2 should be devoid of [}svchoactive side effects of marijuana.
该研究建议的长期目标是确定分子基础的基础
CB2大麻素受体。为了实现此目的,将采取以下步骤。在AIM 1和2中
将进行互动诱变,分子建模和新的化合物测试研究。
这种结合的方法提高了我们的理解,应该继续揭示有关的新见解
如何通过其受体识别大麻素配体,受体亚型选择的起源和
这些受体如何被激活/灭活。大麻素受体共享许多保守的
在其他良好研究的G蛋白偶联受体(GPCR)中看到的序列基序,例如Rhodopsin和
生物胺受体。但是,几个螺旋弯曲的残基和图案以及一个关键的二硫化物
大麻素受体中缺少许多其他GPCR中的桥梁。在AIM 3中,配体绑定
CB2大麻素受体的两个跨膜结构域的缝隙暴露将使用
取代的半胱氨酸可及性法。这种方法应阐明结构和功能
大麻素受体的这些trasmemmbrane结构域中序列差异的后果。在
AIM 4,CB2受体的二硫键形成将直接通过最新出现确定
质谱法的方法论。研究独特的二硫键或二硫键
债券应提供CB2受体的重要螺旋折叠信息,这将具有重要的
该受体的配体结合缝隙和激活机制的含义。最后,目标
5,努力将用于过表达和净化大量功能CB2受体。这
具有挑战性的任务,如果成功完成,则应通过提供严重的影响产生重大影响
需要纯的受体蛋白,以进行未来的高分辨率生物物理研究。总体而言,这项研究应该
帮助我们以更分子的细节了解CB2受体的结构和功能。 CB2是
主要分布在免疫系统中。这对于免疫调节作用非常重要
大麻。从长远来看,这项研究还应帮助我们开发更好的大麻素模拟物
治疗免疫系统疾病,例如炎症和自身免疫性疾病。毒品
soecifi(;在CB2上打击的ALLV应没有[} svChoActive副作用的副作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZHAO-HUI SONG其他文献
ZHAO-HUI SONG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZHAO-HUI SONG', 18)}}的其他基金
Endocannabinoid system as a therapeutic target for PVR
内源性大麻素系统作为 PVR 的治疗靶点
- 批准号:
10747004 - 财政年份:2023
- 资助金额:
$ 4.04万 - 项目类别:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
大麻素受体和新型抗青光眼药物
- 批准号:
7655084 - 财政年份:2003
- 资助金额:
$ 4.04万 - 项目类别:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
大麻素受体和新型抗青光眼药物
- 批准号:
6774098 - 财政年份:2003
- 资助金额:
$ 4.04万 - 项目类别:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
大麻素受体和新型抗青光眼药物
- 批准号:
7895529 - 财政年份:2003
- 资助金额:
$ 4.04万 - 项目类别:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
大麻素受体和新型抗青光眼药物
- 批准号:
6923583 - 财政年份:2003
- 资助金额:
$ 4.04万 - 项目类别:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
大麻素受体和新型抗青光眼药物
- 批准号:
7095301 - 财政年份:2003
- 资助金额:
$ 4.04万 - 项目类别:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
大麻素受体和新型抗青光眼药物
- 批准号:
6681560 - 财政年份:2003
- 资助金额:
$ 4.04万 - 项目类别:
Structure and Function of CB2 Cannabinoid Receptor
CB2 大麻素受体的结构和功能
- 批准号:
7061327 - 财政年份:1998
- 资助金额:
$ 4.04万 - 项目类别:
Structure and Function of CB2 Cannabinoid Receptor
CB2 大麻素受体的结构和功能
- 批准号:
6886758 - 财政年份:1998
- 资助金额:
$ 4.04万 - 项目类别:
Structure and Function of CB2 Cannabinoid Receptor
CB2 大麻素受体的结构和功能
- 批准号:
6723452 - 财政年份:1998
- 资助金额:
$ 4.04万 - 项目类别:
相似国自然基金
基因与家庭不利环境影响儿童反社会行为的表观遗传机制:一项追踪研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
不利地质结构对地下洞室群围岩地震响应影响研究
- 批准号:51009131
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
列车制动力对铁路桥梁的作用机理及最不利影响的研究
- 批准号:50178004
- 批准年份:2001
- 资助金额:23.0 万元
- 项目类别:面上项目
相似海外基金
Identification of allosteric molecules for DOR-KOR heteromer-mediated peripheral analgesia
DOR-KOR 异聚体介导的外周镇痛变构分子的鉴定
- 批准号:
10608439 - 财政年份:2023
- 资助金额:
$ 4.04万 - 项目类别:
Synthesis of peripherally active CB1 agonists as analgesics
作为镇痛药的外周活性 CB1 激动剂的合成
- 批准号:
10398527 - 财政年份:2021
- 资助金额:
$ 4.04万 - 项目类别:
Effects of Long-Term Morphine Treatment on Opioid Receptor Signaling and Inflammation in the Chronic Post-TBI Period
长期吗啡治疗对慢性 TBI 后阿片受体信号传导和炎症的影响
- 批准号:
10454092 - 财政年份:2019
- 资助金额:
$ 4.04万 - 项目类别:
Pharmacological Probes based on mitragynine pseudoindoxyl
基于帽柱木碱假吲哚酚的药理探针
- 批准号:
9765241 - 财政年份:2018
- 资助金额:
$ 4.04万 - 项目类别:
Pharmacological Probes based on mitragynine pseudoindoxyl
基于帽柱木碱假吲哚酚的药理探针
- 批准号:
10209056 - 财政年份:2018
- 资助金额:
$ 4.04万 - 项目类别: